Research Article| Volume 50, ISSUE 6, P513-518, September 2012

Subset of patients with verrucous carcinoma of the oral cavity who benefit from treatment with methotrexate

Published:October 17, 2011DOI:


      Oral verrucous carcinoma (OVC) is a low-grade variant of squamous cell carcinoma (SCC) with a distinctive morphology and specific pattern of behaviour that is often diagnosed in elderly patients. Resection is the treatment of choice, with radiotherapy as a reasonable alternative. In this retrospective case review we present our experience and outcomes in a group of 12 patients with various stages of OVC who had not been treated conventionally because of the extent of their lesions and their poor general condition. All patients were given chemotherapy with methotrexate, which was given by various routes and in different doses during the period 1972–2010. In 11 patients treatment with methotrexate alone was beneficial. One patient failed to respond. Methotrexate used alone as chemotherapy may minimise morbidity and improve quality of life, particularly among elderly patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kamath V.V.
        • Varma R.R.
        • Gadewar D.R.
        • Muralidhar M.
        Oral verrucous carcinoma. An analysis of 37 cases.
        J Craniomaxillofac Surg. 1989; 17: 309-314
        • Rekha K.P.
        • Angadi P.V.
        Verrucous carcinoma of the oral cavity: a clinico-pathologic appraisal of 133 cases in Indians.
        Oral Maxillofac Surg. 2010; 14: 211-218
        • Koch B.B.
        • Trask D.K.
        • Hoffman H.T.
        • Karnell L.H.
        • Robinson R.A.
        • Zhen W.
        National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcome.
        Cancer. 2001; 92: 110-120
        • Oliveira D.T.
        • de Moraes R.V.
        • Fiamengui Filho J.F.
        • Fanton Neto J.
        • Landman G.
        • Kowalski L.P.
        Oral verrucous carcinoma: a retrospective study in São Paulo Region, Brazil.
        Clin Oral Investig. 2006; 10: 205-209
        • Huang T.T.
        • Hsu L.P.
        • Hsu Y.H.
        • Chen P.R.
        Surgical outcome in patients with oral verrucous carcinoma: long-term follow-up in an endemic betel quid chewing area.
        J Otorhinolaryngol Relat Spec. 2009; 71: 323-328
        • Walvekar R.R.
        • Chaukar D.A.
        • Deshpande M.S.
        • Pai P.S.
        • Chaturvedi P.
        • Kakade A.
        Verrucous carcinoma of the oral cavity: a clinical and pathological study of 101 cases.
        Oral Oncol. 2009; 45: 47-51
        • Shear M.
        • Pindborg J.J.
        Verrucous hyperplasia of the oral mucosa.
        Cancer. 1980; 46: 1855-1862
        • Batsakis J.G.
        • Suarez P.
        • el-Naggar A.K.
        Proliferative verrucous leukoplakia and its related lesions.
        Oral Oncol. 1999; 35: 354-359
        • Bagan J.
        • Scully C.
        • Jimenez Y.
        • Martorell M.
        Proliferative verrucous leukoplakia: a concise update.
        Oral Dis. 2010; 16: 328-332
        • Kang C.J.
        • Chang J.T.
        • Chen T.M.
        • Chen I.H.
        • Liao C.T.
        Surgical treatment of oral verrucous carcinoma.
        Chang Gung Med J. 2003; 26: 807-812
        • Yoshimura Y.
        • Mishima K.
        • Obara S.
        • Nariai Y.
        • Yoshimura H.
        • Mikami T.
        Treatment modalities for oral verrucous carcinomas and their outcomes: contribution of radiotherapy and chemotherapy.
        Int J Clin Oncol. 2001; 6: 192-200
        • Ferlito A.
        • Rinaldo A.
        • Mannarà G.M.
        Is primary radiotherapy an appropriate option for the treatment of verrucous carcinoma of the head and neck?.
        J Laryngol Otol. 1998; 112: 132-139
        • Wu C.F.
        • Chen C.M.
        • Shen Y.S.
        • Huang I.Y.
        • Chen C.H.
        • Chen C.Y.
        Effective eradication of oral verrucous carcinoma with continuous intraarterial infusion chemotherapy.
        Head Neck. 2008; 30: 611-617
        • Sheen M.C.
        • Sheu H.M.
        • Lai F.J.
        • Lin S.D.
        • Wu C.F.
        • Wang Y.W.
        A huge verrucous carcinoma of the lower lip treated with intra-arterial infusion of methotrexate.
        Br J Dermatol. 2004; 151: 727-729
        • Grinspan D.
        • Abulafia J.
        Oral florid papillomatosis (verrucous carcinoma).
        Int J Dermatol. 1979; 18: 608-622
        • Dame H.
        • Schuh F.D.
        • Hull D.C.
        Verrucous carcinoma of the buccal mucosa.
        South Med J. 1974; 67: 1070-1072
        • Kanee B.
        Oral florid papillomatosis complicated by verrucous squamous carcinoma. Treatment with methotrexate.
        Arch Dermatol. 1969; 99: 196-202
        • Van der Beek J.M.
        • Cremers C.W.
        • van den Broek P.
        Successful methotrexate therapy in oral florid papillomatosis.
        Clin Otolaryngol Allied Sci. 1980; 5: 365-371
        • Kolokythas A.
        • Rogers T.M.
        • Miloro M.
        Hybrid verrucous squamous carcinoma of the oral cavity: treatment considerations based on a critical review of the literature.
        J Oral Maxillofac Surg. 2010; 68: 2320-2324
        • Strojan P.
        • Ferlito A.
        • Wu C.F.
        • Rinaldo A.
        Intraarterial chemotherapy: a valid option in the treatment of verrucous carcinoma?.
        Eur Arch Otorhinolaryngol. 2010; 267: 835-837